Both medications work — but differently.
Semaglutide activates one receptor (GLP-1) and delivers an average of ~15% body weight reduction. Tirzepatide activates two receptors (GLP-1 + GIP) and has shown up to 22% weight loss in clinical trials — making it the more powerful option for many patients. The best choice depends on your health history, goals, and provider recommendation.
What Is Semaglutide?
Semaglutide belongs to a class of medications known as GLP-1 receptor agonists. It works by mimicking a naturally occurring hormone that your body produces after eating — helping regulate appetite, blood sugar, digestion, and feelings of fullness.
By slowing stomach emptying and reducing hunger signals sent to the brain, semaglutide helps many patients consume fewer calories without constantly feeling deprived. It has become one of the most widely recognized medications in weight management, with extensive clinical data supporting its safety and effectiveness.
Luma Health's compounded Semaglutide contains the same active ingredient as Ozempic® and Wegovy® — physician-prescribed and personalized to your dose — starting at $90/month. Free 2–3 day shipping included.
How Semaglutide Works
- Reduces hunger signals sent to the brain
- Slows digestion so you feel full longer
- Increases feelings of satiety after smaller portions
- Improves blood sugar control and insulin response
- Reduces cravings and emotional eating impulses
What Is Tirzepatide?
Tirzepatide is a newer, next-generation medication that works through a dual-action mechanism. Unlike semaglutide — which targets only GLP-1 receptors — tirzepatide simultaneously activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors.
Researchers believe this dual mechanism helps improve appetite control, insulin sensitivity, and overall metabolic function more powerfully than GLP-1 activation alone. Many experts consider tirzepatide one of the most significant advances in obesity medicine in recent years.
Luma Health's compounded Tirzepatide contains the same active ingredient as Mounjaro® and Zepbound® — physician-prescribed with personalized dosing — at $165/month. Free 2–3 day shipping included.
How Tirzepatide Works
- Activates GLP-1 receptors — same mechanism as semaglutide
- Also activates GIP receptors for enhanced appetite suppression
- Improves insulin sensitivity more broadly
- Greater metabolic regulation through dual-pathway action
- Increases fullness signals more powerfully than single-agonist medications
Side-by-Side Comparison
| Semaglutide | Tirzepatide | |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | Dual GIP + GLP-1 agonist |
| Brand equivalents | Ozempic®, Wegovy® | Mounjaro®, Zepbound® |
| Avg. weight loss | ~15% body weight* | Up to 22% body weight* More powerful |
| Dosing | Once weekly injection | Once weekly injection |
| Oral option | Available → | Available → |
| Luma Health price | $90/month | $165/month |
| Clinical history | Longer — more long-term data | Newer — rapidly growing evidence |
| FSA/HSA eligible | ✅ Yes | ✅ Yes |
*Based on clinical trial data. Individual results will vary.
Weight Loss Results
Clinical studies consistently show that tirzepatide produces greater average weight loss than semaglutide for many patients. However, this does not mean semaglutide is ineffective — both medications have delivered meaningful, life-changing results when combined with healthy lifestyle changes.
The factors that most influence outcomes include starting weight, diet quality, exercise habits, sleep, consistency with treatment, and underlying medical conditions. Sustainable weight loss always depends on more than medication alone.
Both work. One may work better for you.
Your Luma provider reviews your full health history and recommends the treatment most likely to succeed for your specific body and goals. Complete a free assessment and get matched same day.
Side Effects: What to Expect
Both medications can cause similar side effects, particularly during the early weeks of treatment or when your dose increases. Most patients find these symptoms improve significantly as their body adjusts.
Common side effects for both medications:
- Nausea — most common early on, typically improves within weeks
- Constipation or loose stools
- Stomach discomfort or bloating
- Reduced appetite (often the desired effect)
- Occasional fatigue during dose adjustment
Your Luma provider starts you at the lowest effective dose and titrates slowly to minimize side effects. Our FAQ page covers the most common questions about managing side effects on GLP-1 therapy.
Which Medication Is Right for You?
Not sure which is right for you? That's exactly what your Luma provider is for. View all treatments → or complete a free health assessment to get a personalized recommendation.
Luma also offers no-injection oral options: Oral Semaglutide and Oral Tirzepatide — same active ingredients, no needles required.
Frequently Asked Questions
Tirzepatide activates both GLP-1 and GIP receptors, while semaglutide activates only GLP-1 receptors. Clinical studies suggest tirzepatide may produce greater average weight loss — up to 22% vs ~15% — in many patients. However, individual response varies.
Results vary significantly between individuals. Some clinical studies have shown greater average weight loss with tirzepatide, but personal response differs from patient to patient based on starting weight, lifestyle, and biology. Your Luma provider will help identify the best option for your goals.
Both medications produce similar gastrointestinal side effects. The severity depends on dosage, individual tolerance, and how gradually the dose is increased. Your Luma provider starts at the lowest effective dose and adjusts slowly to minimize discomfort.
Yes — in some situations your provider may recommend transitioning. This should always be done under medical guidance with appropriate dose adjustments. Message your Luma care team at any time to discuss switching options.
Yes — Luma Health offers both Oral Semaglutide and Oral Tirzepatide as daily tablets. Same active ingredients, no injections required. Both are $100/month.